Trypanothione as a Target in the Design of Antitrypanosomal and Antileishmanial Agents

Authors: Augustyns, K.; Amssoms, K.; Yamani, A.; Rajan, P.K.; Haemers, A.

Source: Current Drug Metabolism, Volume 7, Number 12, 1 August 2001 , pp. 1117-1141(25)

Publisher: Bentham Science Publishers

Buy & download fulltext article:

Price: $63.10 plus tax (Refund Policy)

Abstract:

Trypanothione is the key molecule in the defence mechanism of Trypanosoma and Leishmania against oxidative stress. The uniqueness of trypanothione makes the metabolism of this molecule an attractive target in antitrypanosomal and antileishmanial drug design. It became clear that this antioxidant cascade can be considered as the Achilles heel of these parasites.

The following targets and their respective inhibitors will be discussed biosynthesis of trypanothione with glutathionylspermidine synthetase and trypanothione synthetase biosynthesis of glutathione with gama-glutamylcysteine synthetase biosynthesis of spermidine with ornithine decarboxylase trypanothione hydroperoxide metabolism with tryparedoxine peroxidase, tryparedoxine and trypanothione reductase.

Keywords: Trypanothione; Antitrypanosomal; Antileishmanial Agents; oxidative stress; glutathionylspermidine synthetase; trypanothione synthetase; g-glutamylcysteine; spermidine; ornithine; decarboxylase

Document Type: Review article

DOI: http://dx.doi.org/10.2174/1381612013397564

Publication date: 2001-08-01

More about this publication?

Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.